Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 10:52 p.m.

    📋 Y-MABS THERAPEUTICS, INC. (YMAB) - Regulatory Update

    Filing Date: 2022-05-31

    Accepted: 2022-05-31 09:17:32

    Event Type: Regulatory Update

    Event Details:

    Y-mAbs Therapeutics Inc (YMAB) Announces Regulatory Update Y-mAbs Therapeutics Inc (YMAB) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: • PDUFA Date: december 31, 2021 • Applications: BLA (Biologics License Application), NDA (New Drug Application) • Designations: Priority Review • Regulatory Agencies: FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency) • Status: Approved, Rejected, Delayed • Committee Actions: Advisory Committee Meeting Clinical Development:

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Y-mAbs Therapeutics Inc
    • CIK: 0001722964
    • Ticker Symbol: YMAB
    • Period End Date: 2022-05-31
    • Document Type: 8-K

Search

News categories